Masimo Corporation (MASI)

US — Healthcare Sector
Peers: GMED  PODD  INSP  NVCR  IDXX  PAYC  DXCM  RMD 

Automate Your Wheel Strategy on MASI

With Tiblio's Option Bot, you can configure your own wheel strategy including MASI - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol MASI
  • Rev/Share 34.2259
  • Book/Share 19.3111
  • PB 7.6407
  • Debt/Equity 0.6158
  • CurrentRatio 2.1446
  • ROIC -0.1079

 

  • MktCap 8015626011.0
  • FreeCF/Share 2.7481
  • PFCF 54.0137
  • PE -17.3513
  • Debt/Assets 0.2673
  • DivYield 0
  • ROE -0.4078

 

  • Rating C-
  • Score 1
  • Recommendation Strong Sell
  • P/E Score 1
  • DCF Score 4
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Reiterated MASI Raymond James -- Outperform $170 $194 Dec. 27, 2024

News

Masimo (MASI) Reports Q4 Earnings: What Key Metrics Have to Say
MASI
Published: February 25, 2025 by: Zacks Investment Research
Sentiment: Positive

Although the revenue and EPS for Masimo (MASI) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Read More
image for news Masimo (MASI) Reports Q4 Earnings: What Key Metrics Have to Say
Masimo (MASI) Tops Q4 Earnings and Revenue Estimates
MASI
Published: February 25, 2025 by: Zacks Investment Research
Sentiment: Positive

Masimo (MASI) came out with quarterly earnings of $1.80 per share, beating the Zacks Consensus Estimate of $1.49 per share. This compares to earnings of $1.25 per share a year ago.

Read More
image for news Masimo (MASI) Tops Q4 Earnings and Revenue Estimates
Masimo Corporation (MASI) Q4 2024 Earnings Call Transcript
MASI
Published: February 25, 2025 by: Seeking Alpha
Sentiment: Neutral

Masimo Corporation (NASDAQ:MASI ) Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ET Company Participants Eli Kammerman - Vice President, Business Development & Investor Relations Katie Szyman - Chief Executive Officer Micah Young - Chief Financial Officer Conference Call Participants Marie Thibault - BTIG Jason Bednar - Piper Sandler Rick Wise - Stifel Michael Polark - Wolfe Research Vik Chopra - Wells Fargo Mike Matson - Needham Operator Good afternoon, ladies and gentlemen, and welcome to Masimo's Fourth Quarter and Full Year 2024 Earnings Conference Call. The company's press release is available at www.masimo.com.

Read More
image for news Masimo Corporation (MASI) Q4 2024 Earnings Call Transcript
Masimo Tops EPS, Revenue Expectations
MASI
Published: February 25, 2025 by: The Motley Fool
Sentiment: Positive

Masimo (MASI -0.69%), a provider of noninvasive patient monitoring technology, released its fourth-quarter earnings for 2024, on Feb. 25, 2025. The results presented a mixed picture: strong performance was seen in its core healthcare segment, with revenue reaching $601 million, surpassing analyst expectations of $592 million.

Read More
image for news Masimo Tops EPS, Revenue Expectations

About Masimo Corporation (MASI)

  • IPO Date 2007-08-08
  • Website https://www.masimo.com
  • Industry Medical - Instruments & Supplies
  • CEO Catherine M. Szyman
  • Employees 3600

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.